Tasly Pharmaceutical Group Co., Ltd.
A pioneer in the modernization of traditional Chinese medicine, the publicly traded Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 by Yan Xijun and his wife Wu Naifeng in Tianjin, China. The couple who met while training as pharmacists at a military medical school, had developed a new method to extract the active substance from Danshen, or red sage root, an herbal ingredient known to be effective in treating heart diseases. The active substance presented as “dripping pills” became the main product of Tasly, capturing 36% market share of this proprietary Chinese medecine. In 2005, the couple’s son Kaijing joined the company and in 2014 took over from his father Xijun as chairman of Tasly. Xijun had planned and executed his succession with military precision, ensuring that a professional management team was put in place to head the group while he and his wife, the first generation, took their leave as planned.
This case sets the scene for a discussion on succession planning and governance in a publicly traded family business.
Tasly Pharmaceutical, Healthcare, Pharmaceuticals
1994-2014
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
We investigate family CEO birth order as an antecedent of family firms' CSR behavior. Despite psychology literature recognizing it as a key predictor of individual behavior, birth order has been largely neglected in management research. Drawing on...
Non-family managers play a crucial role in fostering innovation within family firms, yet their impact remains debated due to inconsistent research findings and a lack of comprehensive synthesis. This study integrates this effect through a meta-ana...
Family offices are experiencing unprecedented growth, with an estimated 17,000 worldwide and nearly 10,000 established in just the last fifteen years (EY, 2022). Yet despite this rapid expansion, academic research has struggled to keep pace with p...
Family firms are often portrayed as cohesive systems driven by strong family leadership. But what happens when these firms grow complex, operate across multiple business units, and rely heavily on nonfamily managers? After all, nonfamily employees...
In entrepreneurial families, complexity lies primarily in their ongoing interaction with the family.
Belonging is important because it is what holds an organisation together when complexity increases. It is not a “soft” feeling: it is an operational condition. When people experience a sense of belonging to a recognisable “us”, coordination costs ...
Research Information & Knowledge Hub for additional information on IMD publications
in Strategic Entrepreneurship Journal March 2026, vol. 20, no. 1, pp. 49-78, https://doi.org/10.1002/sej.1530
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Family Business Review March 2026, vol. 39, no. 1, pp. 40-62, https://doi.org/10.1177/08944865251393043
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in FamilyBusiness.org 13 February 2026
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in We Wealth February 2026, no. 87, pp. 48-49
Research Information & Knowledge Hub for additional information on IMD publications